These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1955735)
21. Transforming growth factor-beta does not alter interleukin-1 expression in cultured human macrophages. Hurme M; Sihvola M; Alitalo K; Keski-Oja J J Cell Biochem; 1989 Apr; 39(4):467-75. PubMed ID: 2470767 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Bellinghausen I; König B; Böttcher I; Knop J; Saloga J Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154 [TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Turley JM; Falk LA; Ruscetti FW; Kasper JJ; Francomano T; Fu T; Bang OS; Birchenall-Roberts MC Cell Growth Differ; 1996 Nov; 7(11):1535-44. PubMed ID: 8930403 [TBL] [Abstract][Full Text] [Related]
26. Human NK cell IFN-gamma production is regulated by endogenous TGF-beta. Meadows SK; Eriksson M; Barber A; Sentman CL Int Immunopharmacol; 2006 Jun; 6(6):1020-8. PubMed ID: 16644489 [TBL] [Abstract][Full Text] [Related]
27. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types. Fujita T; Teramoto K; Ozaki Y; Hanaoka J; Tezuka N; Itoh Y; Asai T; Fujino S; Kontani K; Ogasawara K Cancer Res; 2009 Jun; 69(12):5142-50. PubMed ID: 19491278 [TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Yang F; Strand DW; Rowley DR Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743 [TBL] [Abstract][Full Text] [Related]
30. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors. Yoshizawa M; Miyazaki H; Kojima S J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509 [TBL] [Abstract][Full Text] [Related]
31. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198 [TBL] [Abstract][Full Text] [Related]
32. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice. Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496 [TBL] [Abstract][Full Text] [Related]
33. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800 [TBL] [Abstract][Full Text] [Related]
34. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Koli K; Keski-Oja J Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362 [TBL] [Abstract][Full Text] [Related]
35. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1. Espevik T; Figari IS; Ranges GE; Palladino MA J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680 [TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400 [TBL] [Abstract][Full Text] [Related]
38. Regulation of immune responses by TGF-beta. Letterio JJ; Roberts AB Annu Rev Immunol; 1998; 16():137-61. PubMed ID: 9597127 [TBL] [Abstract][Full Text] [Related]
39. Review of the activation of TGF-beta in immunity. Taylor AW J Leukoc Biol; 2009 Jan; 85(1):29-33. PubMed ID: 18818372 [TBL] [Abstract][Full Text] [Related]